Differential gene expression and genomic patient stratification following left ventricular assist device support.

[1]  Robert L Kormos,et al.  Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  J. Towbin,et al.  Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy , 2002, The Lancet.

[3]  R. Hetzer,et al.  Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. , 2001, Journal of the American College of Cardiology.

[4]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[5]  D. Mann,et al.  Differential Regulation of Mitogen-Activated Protein Kinases in the Failing Human Heart in Response to Mechanical Unloading , 2001, Circulation.

[6]  J. Mesirov,et al.  Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Feldman,et al.  Downregulation of Matrix Metalloproteinases and Reduction in Collagen Damage in the Failing Human Heart After Support With Left Ventricular Assist Devices , 2001, Circulation.

[8]  D. Burkhoff,et al.  Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. , 2001, The Journal of thoracic and cardiovascular surgery.

[9]  G. Noon,et al.  Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  R. Hetzer,et al.  Bridging-to-recovery. , 2001, The Annals of thoracic surgery.

[11]  R. Hetzer,et al.  Predictive factors for weaning from a cardiac assist device. An analysis of clinical, gene expression, and protein data. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  J. Towbin,et al.  Improved myocardial structure following LVAD support: effect of unloading on dystrophin expression. , 2001, The Journal of Heart and Lung Transplantation.

[13]  J. Farmer,et al.  The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. , 2000, American journal of surgery.

[14]  G. Tenderich,et al.  Predictors of survival in patients bridged to transplantation with the thoratec VAD device: a single-center retrospective study on more than 100 patients. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  H. Taegtmeyer.  Metabolism--the lost child of cardiology. , 2000, Journal of the American College of Cardiology.

[16]  M C Oz,et al.  Left ventricular assist device-induced reverse ventricular remodeling. , 2000, Progress in cardiovascular diseases.

[17]  H. Baba,et al.  Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  K. Vranizan,et al.  Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.

[20]  G. Noon,et al.  Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. , 1999, Circulation.

[21]  R Hetzer,et al.  Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. , 1999, The Annals of thoracic surgery.

[22]  M Flannery,et al.  Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. , 1998, Circulation.

[23]  M C Oz,et al.  Implantable left ventricular assist devices. , 1998, The New England journal of medicine.

[24]  R. Reneman,et al.  Transcriptional regulation of metabolic processes: implications for cardiac metabolism , 1998, Pflügers Archiv.

[25]  S. Houser,et al.  Regression of cellular hypertrophy after left ventricular assist device support. , 1998, Circulation.

[26]  M. Oz,et al.  Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. , 1998, The Journal of thoracic and cardiovascular surgery.

[27]  S. Houser,et al.  Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. , 1998, Circulation.

[28]  RolandHetzer,et al.  Weaning From Mechanical Cardiac Support in Patients With Idiopathic Dilated Cardiomyopathy , 1997 .

[29]  V. Jeevanandam,et al.  Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  M. Oz,et al.  Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. , 1997, The Annals of thoracic surgery.

[31]  R. Doughty,et al.  Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease , 1997 .

[32]  O. Frazier,et al.  Improved left ventricular function after chronic left ventricular unloading. , 1996, The Annals of thoracic surgery.

[33]  H Harasaki,et al.  Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. , 1996, Journal of the American College of Cardiology.

[34]  M C Oz,et al.  Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. , 1995, Circulation.

[35]  M. Quiñones,et al.  Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. , 1995, Circulation.

[36]  P. Grayburn,et al.  Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. , 1995, Journal of the American College of Cardiology.

[37]  H Harasaki,et al.  Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group. , 1994, Circulation.

[38]  B. Griffith,et al.  Evolution of human cardiac myocyte dimension during prolonged mechanical support. , 1991, The Journal of thoracic and cardiovascular surgery.